Jean–Pierre Bronowicki

Author

Also Known As

Albert Tran, Alexandre Bolle, Bronowiccki, JP, Bronowicki, Jean-Pierre, Jean-Pierre BRONOWICKI, Jean-Pierre Bronowicki, Jean-Pierre. Bronowicki, Jean‐Pierre Bronowicki, Jean–Pierre Bronowicki, Nouel, Olivier

258

Publications

17.9K

Citations

H-Index

110

Concepts

All Affiliations

Inserm Centre Hospitalier Régional et Universitaire de Nancy Université de Lorraine Sorbonne Université Assistance Publique – Hôpitaux de Paris

About

Jean–Pierre Bronowicki is an author at Inserm specializing in medicine, hepatology, and hepatitis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	61	8.4K
2	Health Sciences	11	12	1.4K
3	Public Health	6	8	1.2K
4	Engineering	2	2	139
5	Natural Sciences	2	2	383

Jean–Pierre Bronowicki

112

Publications

16.9K

Citations

H-Index

Page 1

	Year	Citations
Boceprevir for Untreated Chronic HCV Genotype 1 Infection Fred Poordad, Jonathan McCone, Bruce R. Bacon, New England Journal of Medicine	2011	2.5K
Telaprevir and Peginterferon with or without Ribavirin for Chronic HCV Infection Christophe Hézode, Nicole Forestier, Geoffrey Dusheiko, New England Journal of Medicine	2009	1K
Regression of Splenic Lymphoma with Villous Lymphocytes after Treatment of Hepatitis C Virus Infection Olivier Hermine, François Lefrère, Jean–Pierre Bronowicki, New England Journal of Medicine	2002	798
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study Fabrice Carrat, Hélène Fontaine, Céline Dorival, The Lancet HepatologyHepatitis CViral HepatitisClinical EpidemiologyChronic Hepatitis C	2019	612
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis Christophe Corpechot, Olivier Chazouillères, Alexandra Rousseau, New England Journal of Medicine	2018	567
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications Pierre Nahon, Valérie Bourcier, Richard Layese, Gastroenterology HepatologyHepatitis CViral HepatitisLiver PhysiologyHepatitis	2016	530
Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: A retrospective multicenter study Richard Moreau, François Durand, Thierry Poynard, Gastroenterology Type 1HepatologyLiver PhysiologyHepatitisPathology	2002	467
Patient-to-Patient Transmission of Hepatitis C Virus during Colonoscopy Jean–Pierre Bronowicki, Véronique Venard, C. Botté, New England Journal of Medicine Therapeutic ProceduresViral DiagnosticsHepatitis C VirusGastroenterologyPathology	1997	434
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890 Christophe Hézode, Hélène Fontaine, Céline Dorival, Journal of Hepatology HepatologyAnrs Co20-cupicViral HepatitisTriple TherapyHepatitis	2013	431
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial Shukui Qin, Minshan Chen, Ann‐Lii Cheng, The Lancet Surgical OncologyHepatologyMedicinePathologyHigh-risk Hepatocellular Carcinoma	2023	415

Page 1